Plunkett's Health Care Industry Almanac 2018

Erscheinungsjahr 2017
ISBN: 978-1-62831-455-7
Verlag: Plunkett Research, Ltd.

Buch, Englisch, 680 Seiten, Paperback, Format (B × H): 216 mm x 279 mm, Gewicht: 1557 g

Reihe: Plunkett's Industry Almanacs

Plunkett’s Health Care Industry Almanac is the only complete reference to the American Health Care Industry and its leading corporations. No other source provides this massive book’s easy-to-understand comparisons of national health expenditures, emerging technologies, patient populations, hospitals, clinics, corporations, research, Medicare, Medicaid, managed care and many other areas of vital importance. Features dozens of statistical tables covering every aspect of the industry, including Medicare expenditures, hospital utilization, insured and uninsured populations, revenues and health care expenditures as a percent of GDP. In addition, a special area covers health status of the U.S. population. The corporate analysis section features in-depth profiles of the Health Care 500, the largest and most successful firms in health care, public and private, U.S. and international, from leading companies in pharmaceuticals to managed care companies. Details for each corporation include growth plans, subsidiaries and financial results, as well as executives by title, and valuable contact information such as phone and fax numbers, website addresses and headquarters addresses. You'll find a complete overview, industry analysis and market research report in one superb, value-priced package.

Autoren/Hrsg.

Plunkett, Jack W.

Inhaltsverzeichnis

- Introduction 1
- How to Use This Book 3
- Chapter 1: Major Trends and Technologies Affecting the Health Care Industry 7
- 1) Introduction to the Health Care Industry 8
- 2) Continued Rise in Health Care Costs 10
- 3) Employers Fight Rapidly Growing Health Care Premiums/Require Employees to Pay a Significant Share of Costs 11
- 4) Medicare and Medicaid Spending Continue to Surge/More Baby Boomers Hit 65 Years of Age 12
- 5) U.S. Affordable Care Act (ACA) of 2010 Rewrote the Rules and Increased Coverage, But Costs Continue to Rise 12
- 6) Accountable Care Organizations (ACOs) and Hospital Mergers Result from the Affordable Care Act/Many Hospital Chains Grow Dramatically in Market Share 13
- 7) Concierge Care/Direct Primary Care Are on the Rise/New Twists on House Calls 14
- 8) Insurance Companies Change Strategies Due to Affordable Care Act (ACA) and Rapidly Rising Costs of Care 14
- 9) Number of Uninsured Americans Declines But Remains High 15
- 10) New Blockbuster Drugs Come to Market/Drug Prices Soar 15
- 11) Generic Drugs Have Biggest Market Share By Unit Volume, but not by Total Revenues 16
- 12) Coupons and Other Marketing Schemes Obscure the Retail Prices of Drugs in the U.S., Which Are Vastly Higher than Prices Paid in Other Nations 17
- 13) Biotech and Orphan Drugs Create New Revenues for Drug Firms 18
- 14) Quality of Care and Health Care Outcomes Data Are Available Online, Creating a New Level of Transparency 19
- 15) Malpractice Suits Are Blamed for Rising Health Care Costs/Tort Reform Is Capping Awards for Damages 20
- 16) Obesity Sparks Government Action/Snack Foods Get Healthier/Taxes on Unhealthy Foods 21
- 17) Health Care Goes Offshore, Medical Tourism and Clinical Trials Continue in China, India and Elsewhere 23
- 18) Retail Clinics, Urgent Care Centers and Employer Sites Increase Health Care Options/Reduce Costs 24
- 19) Health Care Industry Grows Rapidly in China, India and Mexico 25
- The Outlook for Health Care Technology: 26
- 20) Health Care Technology Introduction 26
- 21) RFID Helps Manage Hospital and Pharmacy Inventories 26
- 22) Electronic Health Records (EHR) Digitize Patient Records at an Accelerating Pace 27
- 23) Telemedicine and Remote Patient Monitoring Rely on Wireless 28
- 24) Stem Cells—Multiple Sources Stem from New Technologies 29
- 25) Government Support for Stem Cell Research Evolves 30
- 26) Stem Cells—Therapeutic Cloning Techniques Advance 30
- 27) Stem Cells—A New Era of Regenerative Medicine Takes Shape 31
- 28) Health Care Robotics 32
- 29) Patients’ Genetic Profiles Plummet in Price as DNA Sequencing Technologies Advance 32
- 30) Advances for Cancer Patients in Chemotherapy and Radiation, Including Proton Beams and IMRT 34
- 31) Better Imaging, including MRI, PET and 320-Slice CT, Creates Advances in Detection 36
- 32) Nanotechnology Makes Breakthroughs in Health Care 38
- 33) Artificial Intelligence (AI), Deep Learning and Machine Learning Advance into Commercial Applications, Including Health Care and Robotics 39
- Chapter 2: Health Care Industry Statistics 41
- I. U.S. Health Care Industry Overview 43
- U.S. Health Care Industry Statistics and Market Size Overview 44
- Global Health Statistics, 2011-2017 45
- Affordable Care Act Overview 46
- Domestic & Foreign Pharmaceutical Sales, PhRMA Member Companies: 1980-2015 47
- Employment in the Health Care Industry, U.S.: 2012- May 2017 48
- Employment & Earnings in Health Care Practitioner & Technical Occupations, U.S.: May 2016 50
- Employment & Earnings in Health Care Support Occupations, U.S.: May 2016 51
- The U.S. Drug Discovery & Approval Process 52
- U.S. FDA New Drug (NDA) and Biologic (BLA) Approvals, 2016 53
- Federal R&D & R&D Plant Funding for National Institutes of Health, U.S.: Fiscal Years 2015-2017 54
- II. U.S. Health Care Expenditures & Costs 55
- The Nation's Health Dollar: 2017 Where It Came From (Estimated) 56
- The Nation's Health Dollar: 2017 Where It Went (Estimated) 57
- National Health Expenditures & Annual Percent Change, U.S.: 2009-2025 58
- National Health Expenditures by Type of Expenditure with Affordable Care Act Impacts, U.S.: Selected Calendar Years, 2010-2025 59
- Hospital Care Expenditures & Annual Percent Change, U.S.: 2009-2025 60
- Nursing Home Care Expenditures & Annual Percent Change, U.S.: 2009-2025 61
- Home Health Care Expenditures & Annual Percent Change, U.S.: 2009-2025 62
- Prescription Drug Expenditures, U.S.: 1995-2025 63
- Prescription Drug Expenditures & Annual Percent Change, U.S.: 2009-2025 64
- III. Medicare & Medicaid 65
- Medicare Enrollment, 1970-2091 66
- Medicare Cost & Non-Interest Income by Source as a Percent of GDP, 1970-2091 67
- Medicare Beneficiaries with Prescription Drug Coverage, Summary Report: July 2017 68
- Medicaid Enrollment & Expenditures for Medical Assistance Payments & Administration: Selected Years, 1966-2025 69
- Medicaid Enrollment and Expenditures, by Enrollment Group: Fiscal Year 2015 70
- IV.U.S. Health Insurance Coverage & The Uninsured 71
- Number & Percent of Persons of All Ages with and without Health Insurance Coverage, U.S.: 1999-2015 72
- Employers' Costs for Health Insurance, Amount & Percent of Total Compensation, U.S.: Selected Years, 2010-2016 73
- V. U.S. Vital Statistics & Population Indicators 75
- Life Expectancy at Age 65, U.S. 76
- Prevalence of Obesity Among Adults, by Age, Sex and Race/Ethnicity: U.S., 2016 77
- Chapter 3: Important Health Care Industry Contacts 79
- (Addresses, Phone Numbers and Internet Sites)
- Chapter 4: THE HEALTH CARE 500: Who They Are and How They Were Chosen 123
- Index of Companies Within Industry Groups 124
- Alphabetical Index 136
- Index of U.S. Headquarters Location by State 138
- Index of Non-U.S. Headquarters Location by Country 141
- Individual Data Profiles on Each of THE HEALTH CARE 500 143
- Additional Indexes
- Index of Hot Spots for Advancement for Women/Minorities 636
- Index by Subsidiaries, Brand Names and Selected Affiliations 638
- A Short Health Care Industry Glossary 657

Über Autor(innen)

Jack W. Plunkett is CEO & Publisher of Plunkett Research, Ltd., a Houston-based provider of market research and industry information in printed and electronic formats. Plunkett Research provides analysis, statistics and other vital data on all major industry sectors, from InfoTech to Retailing to Banking and Nanotechnology. Plunkett's client list includes 10,000 leading corporations, universities and government agencies worldwide. Plunkett's research products are distributed electronically through subscriptions to its website and around the globe by major booksellers and news distributors, including Bloomberg and ThomsonReuters.

Jack Plunkett is the author of numerous books, including The Next Boom: What you absolutely, positively have to know about the world between now and 2025. This book won a 2011 gold medal in the Business Book Awards competition sponsored by Axiom and INC Magazine. Plunkett is frequently interviewed as an expert source by publications such as Time magazine, The Wall Street Journal, The New York Times and Investor's Business Daily, media outlets such as NPR's Marketplace, ABC, and CBS Marketwatch, as well as local and regional newspapers and national columnists. Plunkett received an Academic Book of the Year Award for his Plunkett’s Health Care Industry Almanac, and he was a regional finalist in the Entrepreneur of the Year Awards sponsored by Ernst & Young.